tepoxalin has been researched along with thromboxane b2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnout, J; Baldauf, C; Brunner, F; Chow, A; De Broe, M; De Schepper, PJ; Depré, M; Jurgens, A; Pousset, V; Van Hecken, A; Verbesselt, R; Vermylen, J; Verpooten, GA | 1 |
Kleemeyer, KS; Peskar, BA; Schmidt, K; Willburger, RE; Wittenberg, RH | 1 |
2 trial(s) available for tepoxalin and thromboxane b2
Article | Year |
---|---|
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cyclooxygenase Inhibitors; Double-Blind Method; Gastrointestinal Diseases; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Thromboxane B2 | 1996 |
Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthroplasty, Replacement, Knee; Dinoprostone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Knee Joint; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Male; Middle Aged; Pain; Pain Measurement; Premedication; Pyrazoles; Radioimmunoassay; Synovial Membrane; Thromboxane B2 | 1998 |